Skip to main content

Table 1 Metabolic activity of human PBMCs

From: Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells

  

Metabolic activity [%] of human PBMCs

24 h

48 h

72 h

Cmpd.

C [μg/mL]

MTT

MTT

[3H]-thymidine

ConA

2.5

91.62 ± 19.97

115.67 ± 24.71

*189.69 ± 42.55

*926.57 ± 169.21

α-ecdysone

2

69.76 ± 32.29

84.63 ± 25.67

76.04 ± 26.90

92.27 ± 18.25

10

89.51 ± 22.83

93.81 ± 30.35

85.59 ± 24.40

94.19 ± 19.46

20

91.97 ± 25.74

94.73 ± 23.05

97.07 ± 26.87

94.08 ± 26.97

20-hydroxy ecdysone

2

97.32 ± 20.23

97.69 ± 29.34

105.03 ± 22.52

99.21 ± 21.45

20

100.92 ± 15.48

102.92 ± 27.78

107.60 ± 20.78

100.13 ± 27.84

100

95.68 ± 15.57

102.05 ± 25.34

106.62 ± 22.18

92.71 ± 26.51

sulfadiazine

2

95.74 ± 12.74

103.15 ± 27.05

107.30 ± 26.87

91.24 ± 22.48

20

98.37 ± 18.35

104.37 ± 20.69

107.00 ± 26.21

96.23 ± 24.57

100

100.63 ± 19.82

106.38 ± 26.83

104.51 ± 21.83

89.68 ± 28.18

  1. PBMCs isolated from individuals (N = 61) were tested in the presence of phytoecdysteroids and sulfadiazine in the concentration range between 2 and 100 μg/mL ± SD at the incubation time from 24 to 72 h. The statistically significant differences (p < 0.05) were labeled with an asterisk (*); to calculate the decrease in the metabolic rate compared to the untreated blank, the following equation was used: viability measured using the MTT assay [%] = 100 × sample OD570 (the mean value of the measured optical density of the test samples) / blank OD570 (the mean value of the measured optical density of the untreated cells); using the [3H]-thymidine test: 100 × mean cpm incorporated into treated cells / mean cpm incorporated into cells cultured without phytoecdysteroids